Pear Therapeutics, Inc. along with its affiliate, filed a motion for joint administration of its Chapter 11 bankruptcy case in the US Bankruptcy Court on April 7, 2023. As per the motion, the debtor seeks the joint administration of the case of its affiliate, Pear Therapeutics (US) Inc., with its own case for administrative and procedural purposes. Pear Therapeutics, Inc. has been proposed as the lead debtor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
Mar. 22 | Disclosure Statement and Plan Approved on Interim Basis for Pear Therapeutics, Inc. | CI |
Mar. 04 | Combined Liquidation Plan and Disclosure Statement Filed by Pear Therapeutics, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 142 | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PEARQ Stock
- News Pear Therapeutics, Inc.
- Motion for Joint Administration Filed by Pear Therapeutics, Inc.